BACKGROUND: A significant threat to the public's health is the rise in antimicrobial resistance among numerous nosocomial bacterial infections. This may be a detriment to present initiatives to enhance the health of immune-compromised patients. Consequently, attention has been devoted to exploring new bioactive compounds in the field of drug discovery from endophytes. Therefore, this study is the first on the production of L-tyrosine (LT) as a promising bio-therapeutic agent from endophytic fungi.
RESULTS: A new endophytic fungal isolate has been identified for the first time as Rhizopus oryzae AUMC14899 from Opuntia ficus-indica (L.) and submitted to GenBank under the accession number MZ025968. Separation of amino acids in the crude extract of this fungal isolate was carried out, giving a higher content of LT, which is then characterized and purified. LT exhibited strong antibacterial and anti-biofilm activities against multidrug-resistant Gram-negative and Gram-positive bacteria. The recorded minimum inhibitory concentration (MIC) values ranged from 6 to 20 µg/ml. In addition, LT caused a strong reduction in biofilm formation and disrupted the preformed biofilm. Moreover, results indicated that LT supported cell viability, evidencing hemocompatibility and no cytotoxicity.
CONCLUSION: Our findings suggest that LT has potential as a therapeutic agent due to its potential antibacterial, anti-biofilm, hemocompatibility, and lack of cytotoxic activities, which may also increase the range of therapy options for skin burn infections, leading to the development of a novel fungal-based drug.
Microb Pathog. 2016 Nov;100:213-220
[PMID:
27671284]
ACS Synth Biol. 2018 Sep 21;7(9):2105-2115
[PMID:
30124040]
Science. 2016 Aug 26;353(6302):874-5
[PMID:
27540009]
J Bacteriol. 1973 Nov;116(2):1029-53
[PMID:
4200845]
Appl Environ Microbiol. 2018 May 31;84(12):
[PMID:
29625984]
Burns. 2019 May;45(3):579-588
[PMID:
30385059]
Sci Rep. 2021 Dec 21;11(1):24317
[PMID:
34934098]
Int J Biol Macromol. 2018 Jul 15;114:204-213
[PMID:
29572145]
Antibiotics (Basel). 2020 Jun 17;9(6):
[PMID:
32560458]
PLoS One. 2013 Aug 16;8(8):e72520
[PMID:
23977310]
Science. 2010 Apr 30;328(5978):627-9
[PMID:
20431016]
APMIS. 2007 Aug;115(8):891-9
[PMID:
17696944]
PLoS One. 2020 Mar 10;15(3):e0229589
[PMID:
32155163]
Front Microbiol. 2022 Feb 03;12:705673
[PMID:
35211096]
Int J Mol Sci. 2020 Oct 06;21(19):
[PMID:
33036127]
Int J Nanomedicine. 2017 Aug 21;12:6059-6073
[PMID:
28860766]
Bioengineered. 2020 Dec;11(1):852-861
[PMID:
32749196]
Appl Environ Microbiol. 2002 Nov;68(11):5459-63
[PMID:
12406738]
Proc Natl Acad Sci U S A. 2010 Aug 17;107(33):14799-804
[PMID:
20668241]
J Clin Microbiol. 1985 Dec;22(6):996-1006
[PMID:
3905855]
Front Microbiol. 2018 Sep 21;9:2066
[PMID:
30298054]
Molecules. 2022 Oct 27;27(21):
[PMID:
36364123]
J Appl Biomed. 2022 Feb 16;:
[PMID:
35225438]
Microbiol Res. 2014 Sep-Oct;169(9-10):675-85
[PMID:
24667307]
Future Med Chem. 2015;7(4):493-512
[PMID:
25875875]
Microbiol Res. 2022 Sep;262:127108
[PMID:
35797944]
BMC Complement Altern Med. 2019 Nov 21;19(1):330
[PMID:
31752824]
Biotechnol Lett. 2016 Jun;38(6):1015-9
[PMID:
26969604]
Water Res. 2016 Apr 1;92:173-9
[PMID:
26854605]
Biomater Sci. 2019 May 28;7(6):2611-2622
[PMID:
31020303]
Bioengineered. 2020 Dec;11(1):1080-1083
[PMID:
33094662]
Appl Microbiol Biotechnol. 2022 Mar;106(5-6):1855-1878
[PMID:
35188588]
Int J Food Microbiol. 2021 Apr 16;344:109116
[PMID:
33676332]
Microb Pathog. 2016 Dec;101:89-95
[PMID:
27840224]
Front Microbiol. 2021 Sep 20;12:648560
[PMID:
34616370]
J Bacteriol. 2013 Dec;195(23):5391-5
[PMID:
24097941]
Pharmaceutics. 2012 Feb 16;4(1):179-96
[PMID:
24300187]
Sci Rep. 2020 Aug 6;10(1):13206
[PMID:
32764602]
Acc Chem Res. 2002 Mar;35(3):139-48
[PMID:
11900517]
PLoS One. 2014 Jun 17;9(6):e99513
[PMID:
24936873]
Microbiol Resour Announc. 2019 Jun 6;8(23):
[PMID:
31171621]
Antimicrob Agents Chemother. 2008 Jan;52(1):220-4
[PMID:
17954701]
Antimicrob Agents Chemother. 2014 Aug;58(8):4353-61
[PMID:
24841260]
Int J Biol Macromol. 2019 Feb 1;122:833-843
[PMID:
30404030]
Spectrochim Acta A Mol Biomol Spectrosc. 2006 Nov;65(3-4):802-4
[PMID:
16530470]
Appl Environ Microbiol. 2013 Feb;79(4):1396-9
[PMID:
23220960]
Mol Biol Evol. 2013 Dec;30(12):2725-9
[PMID:
24132122]
Molecules. 2014 Sep 17;19(9):14879-901
[PMID:
25232708]
J Ethnopharmacol. 2011 Apr 12;134(3):803-12
[PMID:
21291988]
Pharm Res. 2018 Nov 7;36(1):5
[PMID:
30406460]
J Appl Biomed. 2022 Jun;20(2):45-55
[PMID:
35727122]
Antibiotics (Basel). 2020 May 08;9(5):
[PMID:
32397205]
Antibiotics (Basel). 2021 Sep 24;10(10):
[PMID:
34680739]
Pol J Microbiol. 2016 Aug 26;65(3):319-329
[PMID:
29334064]
World J Microbiol Biotechnol. 2012 May;28(5):1989-95
[PMID:
22806020]
Sci Rep. 2020 Jun 2;10(1):9021
[PMID:
32488138]
Microbiol Resour Announc. 2019 May 30;8(22):
[PMID:
31147433]
Microb Pathog. 2018 Mar;116:301-312
[PMID:
29407236]
Front Microbiol. 2018 Apr 06;9:683
[PMID:
29681896]
Int J Biol Macromol. 2018 Jul 1;113:1024-1031
[PMID:
29355639]
Planta Med. 2010 Oct;76(14):1479-91
[PMID:
20533165]
Nat Rev Microbiol. 2011 Dec 28;10(2):123-36
[PMID:
22203377]
Front Microbiol. 2021 Jun 22;12:655620
[PMID:
34239507]
Sci Total Environ. 2022 Aug 25;836:155550
[PMID:
35508232]
Microb Pathog. 2020 Jun;143:104164
[PMID:
32198092]
Int J Biol Macromol. 2017 Nov;104(Pt A):732-738
[PMID:
28629858]
Int J Clin Oncol. 2018 Oct;23(5):974-979
[PMID:
29651584]
Sci Rep. 2019 Nov 6;9(1):16152
[PMID:
31695105]
Curr Opin Cell Biol. 2016 Oct;42:102-112
[PMID:
27257751]
Front Microbiol. 2022 Apr 25;13:803688
[PMID:
35547125]
